ORIC (ORIC Pharmaceuticals) 1-Year Share Buyback Ratio: -38.70% (As of Jun. 2026 )

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ORIC ORIC Pharmaceuticals Inc ORIC
34 GF Score
Price $13.74
! 4 Warning Signs
View Full Analysis

What is ORIC Pharmaceuticals 1-Year Share Buyback Ratio?

ORIC Pharmaceuticals ORIC -1.22% 34 1-Year Share Buyback Ratio is -38.70 as of Jun. 2026. GuruFocus rates ORIC with a GF Score™ of 34/100. The stock has 4 warning signs investors should review. Among 1,110 Biotechnology companies, ORIC Pharmaceuticals ranks worse than 71.8% on this metric.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. ORIC Pharmaceuticals's current 1-Year Share Buyback Ratio was -38.70%.

ORIC's 1-Year Share Buyback Ratio is ranked worse than
71.8% of 1110 companies
in the Biotechnology industry
Industry Median: -14.35 vs ORIC: -38.70

ORIC Pharmaceuticals  (NAS:ORIC) 1-Year Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

ORIC Pharmaceuticals 1-Year Share Buyback Ratio Related Terms

ORIC vs ARDX, IMTX, TRAX: 1-Year Share Buyback Ratio Comparison

For the Biotechnology subindustry, ORIC Pharmaceuticals's 1-Year Share Buyback Ratio, along with its competitors' market caps and 1-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ORIC Pharmaceuticals 1-Year Share Buyback Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ORIC Pharmaceuticals's 1-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where ORIC Pharmaceuticals's 1-Year Share Buyback Ratio falls into.


ORIC
34GF Score
ORIC Pharmaceuticals Inc ORIC
1-Year Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ORIC Pharmaceuticals 1-Year Share Buyback Ratio Calculation

ORIC Pharmaceuticals's 1-Year Share Buyback Ratio for the quarter that ended in Jun. 2026 is calculated as

1-Year Share Buyback Ratio=(Shares Outstanding (EOP) (Jun. 2025 ) - Shares Outstanding (EOP) (Jun. 2026 )) / Shares Outstanding (EOP) (Jun. 2025 )
=(86.187 - 103.636) / 86.187
=-20.2%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a 1-Year Share Buyback Ratio of -38.70 mean?
ORIC Pharmaceuticals (ORIC) has a 1-Year Share Buyback Ratio of -38.70 as of Jun. 2026. The 1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. View historical data for ORIC Pharmaceuticals and its competitors. According to the industry distribution chart, ORIC Pharmaceuticals ranks #797 out of 1110 companies in the Biotechnology industry, placing it in the top 71.8%.
Is ORIC Pharmaceuticals' 1-Year Share Buyback Ratio too high?
ORIC Pharmaceuticals' current 1-Year Share Buyback Ratio is -38.70. Based on the distribution chart, ORIC Pharmaceuticals ranks #797 out of 1110 companies in the Biotechnology industry, which is below the industry midpoint. Overall, ORIC Pharmaceuticals has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does ORIC Pharmaceuticals' 1-Year Share Buyback Ratio compare to ARDX and IMTX?
According to the Biotechnology industry distribution chart, ORIC Pharmaceuticals ranks #797 out of 1110 companies for 1-Year Share Buyback Ratio. This places ORIC Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Share Buyback Ratio for a Biotechnology company?
A good 1-Year Share Buyback Ratio depends on the Biotechnology industry context. However, 1-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Share Buyback Ratio mean?
A high 1-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. View historical data for ORIC Pharmaceuticals and its competitors. ORIC Pharmaceuticals's current 1-Year Share Buyback Ratio is -38.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ORIC Pharmaceuticals stock overvalued right now?
ORIC Pharmaceuticals (ORIC) has a current 1-Year Share Buyback Ratio of -38.70. The current 1-Year Share Buyback Ratio is -38.70. ORIC Pharmaceuticals' overall GF Score™ is 34/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Share Buyback Ratio calculated?
1-Year Share Buyback Ratio is calculated from a company's financial statements. For ORIC Pharmaceuticals (ORIC), the current 1-Year Share Buyback Ratio is -38.70 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ORIC Pharmaceuticals Business Description

Other Exchanges 4TZ:Germany
Address 240 E. Grand Avenue, 2nd Floor, South San Francisco, CA, USA, 94080
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
34GF Score

Get the complete analysis for ORIC

1-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.74
Price